ReoPro Observational Registry (RAPOR): insights from the multicentre use of abciximab in Asia.
Lists
Only you see this
Abstract
Abxicimab was uncommonly used among patients (9.4 percent) undergoing PCI in this Asian region, with the operators reserving it mainly for high-risk patients.
BibTeX
@inproceedings{poh2005reopro,
author = {Kian Keong Poh and Huay Cheem Tan and James Yip and Yean Teng Lim},
title = {{ReoPro Observational Registry (RAPOR): insights from the multicentre use of abciximab in Asia.}},
booktitle = {PubMed},
year = {2005},
}Loading related content...